A detailed history of Tyche Wealth Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 4,617 shares of LLY stock, worth $3.45 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
4,617
Previous 4,454 3.66%
Holding current value
$3.45 Million
Previous $4.03 Billion 1.44%
% of portfolio
0.93%
Previous 0.98%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $125,858 - $156,483
163 Added 3.66%
4,617 $4.09 Billion
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $322,567 - $404,522
445 Added 11.1%
4,454 $4.03 Billion
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $546,600 - $731,274
923 Added 29.91%
4,009 $3.12 Billion
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $1.62 Million - $1.91 Million
3,086 New
3,086 $1.8 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tyche Wealth Partners LLC Portfolio

Follow Tyche Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyche Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tyche Wealth Partners LLC with notifications on news.